Cue Biopharma (CUE) Shares Outstanding (Diluted Average) (2021 - 2025)

Cue Biopharma has disclosed Shares Outstanding (Diluted Average) across 5 years of filings, most recently posting $94.7 million for Q4 2025.

• Shares Outstanding (Diluted Average) for Q4 2025 came in at $94.7 million, up 68.18% year-over-year; the trailing twelve-month figure through Dec 2025 was $94.7 million (up 68.18% YoY), and the FY2025 annual result was $94.7 million, up 68.18% from the prior year.
• Shares Outstanding (Diluted Average) came in at $94.7 million for Q4 2025 at Cue Biopharma, down from $100.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $100.9 million in Q3 2025 to a low of $31.3 million in Q4 2021.
• The 5-year median for Shares Outstanding (Diluted Average) is $46.1 million (2023), against an average of $52.4 million.
• Across the five-year window, Shares Outstanding (Diluted Average) rose 8.49% in 2024 and surged 100.56% in 2025, its largest moves.
• Cue Biopharma's Shares Outstanding (Diluted Average) stood at $31.3 million in 2021, then climbed by 13.95% to $35.6 million in 2022, then rose by 28.35% to $45.8 million in 2023, then rose by 23.11% to $56.3 million in 2024, then jumped by 68.18% to $94.7 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $94.7 million (Q4 2025), $100.9 million (Q3 2025), and $84.9 million (Q2 2025), per Business Quant data.